GHK-Cu dosage and protocols
Topical concentrations from 0.1% to 2%. Injectable protocols from 0.5 mg daily to 5 mg three times weekly. Reconstitution math for 50 mg and 100 mg vials. Mesotherapy cocktail dosing. Here are the dosing protocols actually used in research, cosmetic formulation, and peptide-therapy clinics — with honest caveats about which have clinical evidence and which come from community practice.
- Topical cosmetic GHK-Cu is typically formulated at 0.1%–2% concentration; the most-cited clinical trials used 1–2% formulations.
- Injectable systemic GHK-Cu research protocols center on 1–3 mg subcutaneous twice weekly, with higher loading doses sometimes used for the first 4–6 weeks.
- Scalp mesotherapy uses 0.5–1 mg total GHK-Cu per session distributed across 20–40 intradermal injection points.
- Cycles of 8–12 weeks followed by 4-week breaks are common in community protocols though not validated by clinical data.
- Unlike BPC-157 (short half-life, daily dosing), GHK-Cu's gradual signaling action means consistency over weeks matters more than specific single-dose size.
Why GHK-Cu dosing is different from most peptides
Many injectable peptides have short half-lives and require daily dosing to maintain therapeutic effect — BPC-157 is cleared from circulation in under 30 minutes, for instance. GHK-Cu works differently. Its biological effect operates through gene expression modulation and signaling changes that accumulate over days to weeks of consistent exposure. A single GHK-Cu dose doesn't produce measurable change; a 4–6 week protocol does.
This has a practical implication: the difference between "2 mg twice weekly" and "1 mg three times weekly" — same total weekly dose, slightly different frequency — is probably less important for GHK-Cu than it would be for BPC-157 or other short-half-life peptides. What matters more is consistency over the total protocol length, appropriate cumulative exposure, and avoiding large gaps that allow the signaling effect to reset.
Topical dosing
Topical GHK-Cu is measured in percent concentration of the formulated product, not in milligrams per application. The effective concentration range from the clinical literature:
| Concentration | Typical product type | Evidence level | Recommended use |
|---|---|---|---|
| 0.05% | Mass-market low-cost serums | Marginal | May underdeliver; look for higher concentrations |
| 0.1%–0.3% | Entry cosmetic serums | Some clinical support | Adequate for maintenance; consider higher for active problem-solving |
| 0.5%–1% | Standard cosmetic serums | Well-supported in clinical trials | Typical consumer sweet spot — effective without significant irritation risk |
| 1%–2% | Medical-grade / professional | Strongest clinical evidence | Best for active remodeling goals (photoaging, hair loss, scarring) |
| 2%–5% | Specialty / prescription-compounded | Limited evidence for additional benefit | Diminishing returns; higher irritation risk |
Practical topical dosing:
- Apply 2–3 pumps (~0.5–1 mL) of serum to cleansed, dry skin
- 1–2 applications daily — morning and/or evening
- Allow full absorption (2–3 minutes) before layering other products
- For hair/scalp: apply directly to scalp at thinning areas; massage in gently
- Expect 8–12 weeks before visible change; continue for 6+ months for full effect
Subcutaneous injection dosing
Systemic injectable protocols cluster around three patterns:
| Protocol type | Per-dose | Frequency | Total weekly | Cycle length |
|---|---|---|---|---|
| Gentle/starter | 0.5–1 mg | Every other day | 1.5–3.5 mg | 8–12 weeks |
| Standard maintenance | 1–3 mg | 2x per week | 2–6 mg | 8–12 weeks |
| Aggressive loading | 2–5 mg | 3x per week | 6–15 mg | 4–6 weeks, then taper |
| Stack integration | 1–2 mg | Coordinated with BPC-157 or TB-500 schedule | 2–4 mg | 4–8 week stacks |
The most commonly cited practical protocol is 1–3 mg subcutaneous twice weekly. This is the dosing pattern that appears most often in peptide-community literature, compounding pharmacy protocols from the pre-Category-2 era, and aesthetic clinic practice. It is not derived from a formal human dose-ranging study — no such published study exists.
Reconstitution math
Injectable GHK-Cu is supplied as lyophilized powder in 50 mg or 100 mg vials. Reconstitute with bacteriostatic water (BAC water, 0.9% benzyl alcohol for preservation). The reconstitution volume you choose determines the concentration and how many units you'll draw.
The key formula: Vial amount (mg) ÷ reconstitution volume (mL) = concentration (mg/mL). Then target dose (mg) ÷ concentration (mg/mL) = injection volume (mL).
| Vial | + BAC Water | = Concentration | 1 mg dose | 2 mg dose | 3 mg dose | Doses per vial at 2 mg |
|---|---|---|---|---|---|---|
| 50 mg | 2 mL | 25 mg/mL | 4 units | 8 units | 12 units | 25 |
| 50 mg | 3 mL | 16.7 mg/mL | 6 units | 12 units | 18 units | 25 |
| 50 mg | 5 mL | 10 mg/mL | 10 units | 20 units | 30 units | 25 |
| 100 mg | 3 mL | 33.3 mg/mL | 3 units | 6 units | 9 units | 50 |
| 100 mg | 5 mL | 20 mg/mL | 5 units | 10 units | 15 units | 50 |
| 100 mg | 10 mL | 10 mg/mL | 10 units | 20 units | 30 units | 50 |
Units assume a standard U-100 insulin syringe (1 mL = 100 units). Reconstitution volume doesn't change total peptide in the vial — only the concentration and injection volume per dose. More diluent means more volume to inject but easier small-dose measurement; less diluent means less liquid per injection but smaller dose measurements become harder.
Scalp mesotherapy dosing
Scalp mesotherapy is a very different dosing pattern from systemic subcutaneous injection. Rather than a single injection of a larger dose, mesotherapy distributes a small total dose across many intradermal points in the scalp.
| Session parameter | Typical value |
|---|---|
| Total GHK-Cu per session | 0.5–1.5 mg |
| Injection points | 20–40 across thinning areas |
| Dose per injection | 0.02–0.05 mL per point |
| Concentration used | ~1–2% of the injectable solution |
| Depth | Intradermal (~1–3 mm), targeting dermal papilla |
| Frequency (loading) | Weekly for 6–8 weeks |
| Frequency (maintenance) | Monthly thereafter |
| Adjunct ingredients | Biotin, vitamins, other peptides, growth factors |
Mesotherapy sessions are typically performed at aesthetic medicine or hair restoration clinics rather than self-administered, though some users learn the technique for home maintenance after initial clinic sessions.
Cycle length and continuous use
Community peptide-therapy protocols often cycle GHK-Cu — 8–12 weeks on, 4 weeks off — under the rationale that continuous signaling activation may lose effectiveness over time or that breaks allow the body to "reset." There is no published clinical data establishing that cycling is necessary or beneficial for GHK-Cu. In fact, the mechanism (gradual gene expression modulation and signaling reset) suggests that continuous low-to-moderate dosing may be more appropriate than aggressive on-off cycling.
Cosmetic topical use has been studied at continuous daily application over years without evidence of tachyphylaxis (loss of response). Injectable long-term continuous use has much less published data to draw from — which doesn't mean it's worse, just that neither cycling nor continuous use has strong empirical validation in the injectable form.
Dose timing and combination considerations
GHK-Cu's effects are not tied to acute dose timing the way some peptides are. Practical guidance:
- Time of day doesn't appear to matter much — morning or evening injection are both reasonable
- Food timing is irrelevant for injection; for topical, applying to freshly cleansed skin improves penetration
- Combination with other peptides: GHK-Cu can be injected in the same session as BPC-157 or TB-500 (different syringes or same-syringe combination if both peptides are compatible with the chosen BAC water)
- Combination with minoxidil (topical): apply copper peptide serum at a separate time from minoxidil, typically minoxidil in the morning and copper peptides in the evening
- Combination with vitamin C or acids (topical): avoid simultaneous application — use on alternate days or at separated times of day
When in doubt, start low
For injectable protocols, starting at the gentle/starter level (0.5–1 mg every other day) for the first 2 weeks before escalating to maintenance levels is reasonable, especially for users without prior peptide experience. This allows observation of individual tolerance, injection technique practice, and early adverse effect detection before committing to larger doses.
Frequently asked questions
What is the typical GHK-Cu dosage?
Topical: 0.1%–2% concentration in cosmetic serums, applied 1–2 times daily. Injectable: 1–3 mg subcutaneous twice weekly is the most commonly cited protocol; loading phases may use 2–5 mg three times weekly for 4–6 weeks. Scalp mesotherapy: 0.5–1 mg total per session distributed across 20–40 intradermal injection points.
How do I reconstitute a 50 mg GHK-Cu vial?
Add 2 mL of bacteriostatic water to the vial for a concentration of 25 mg/mL. A 1 mg dose is then 0.04 mL (4 units on a U-100 insulin syringe), 2 mg is 8 units, 3 mg is 12 units. Alternative: 5 mL of BAC water gives 10 mg/mL, making dose measurement easier at the cost of larger injection volumes.
How long should a GHK-Cu cycle be?
Community protocols typically run 8–12 weeks followed by a 4-week break, though there is no published clinical data establishing that cycling is necessary. GHK-Cu's mechanism suggests continuous low-to-moderate dosing may be appropriate for long-term use. Topical cosmetic use has been studied at continuous daily application over years without loss of response.
Can I inject GHK-Cu every day?
Yes, daily injection at lower doses (0.5–1 mg) is a reasonable protocol alternative to 2–3x weekly higher-dose protocols. Same total weekly exposure, gentler per-dose tolerability. GHK-Cu's effects accumulate over weeks of consistent exposure rather than from individual high doses, so dose frequency matters less than for short-half-life peptides.
What's the best time to apply topical GHK-Cu?
Either morning or evening works. Apply to cleansed, dry skin and allow 2–3 minutes to absorb before layering other products. Avoid simultaneous application with vitamin C, benzoyl peroxide, or strong acids — separate these by at least several hours or alternate days.